Apogee Therapeutic
APGE----
Apogee Therapeutic (APGE)
Apogee Therapeutics, Inc., a clinical stage biotechnology company, develops novel biologics for the treatment of atopic dermatitis, asthma, eosinophilic esophag...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Apogee Therapeutic Analyst Rating
View MoreForecast & Rating
Jul 24, 2026Price forecast
$130.53-2.79%
Forecast & RatingHold
15analysts
- Strong buy20.00%
- Buy0.00%
- Hold80.00%
- Sell0.00%
- Strong sell0.00%
News
- Motley Fool · Jul 19 at 08:05 PM
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?
- Market Beat · Jul 17 at 04:37 AM
Marks Group Wealth Management Inc Takes $694,000 Position in Apogee Therapeutics Inc. $APGE
- prnewswire · Jul 14 at 03:00 PM
16:00 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRBG, RMAX, GBCS, and APGE
- businessinsider · Jul 14 at 01:00 PM
AbbVie extends slide to a seventh straight session
- Motley Fool · Jul 11 at 09:40 PM
AbbVie Is Already a Dividend King. Here's Why the $10.9 Billion Apogee Deal Could Make It a Dynasty
- PUBT · Jul 10 at 07:01 PM
Apogee Therapeutics CEO Michael Thomas Henderson disposes of USD 2.67 million in common shares
